Vogt-Koyanagi-Harada disease

Seminars in Ophthalmology

Volumn 20, Issue 3, 2005, Pages 183-190

  Damico, Francisco Max ^a   Kiss, Szilárd ^a   Young, Lucy H ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Diagnosis; Eye; Review; Therapy; Uveomeningoencephalitic syndrome

Indexed keywords

AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HLA ANTIGEN; HLA DR ANTIGEN; HLA DR4 ANTIGEN; HLA DW53 ANTIGEN; IMMUNOMODULATING AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; UNCLASSIFIED DRUG;

AUTOIMMUNE DISEASE; B CELL LYMPHOMA; CELLULAR IMMUNITY; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG MEGADOSE; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMMUNOMODULATION; INFERTILITY; LIVER TOXICITY; MELANOCYTE; NEPHROTOXICITY; PAPILLITIS; PATHOGENESIS; PRIORITY JOURNAL; RETINA DETACHMENT; REVIEW; SARCOIDOSIS; SCLERITIS; SIDE EFFECT; SYMPATHETIC OPHTHALMIA; UVEITIS; VOGT KOYANAGI SYNDROME;

DIAGNOSIS, DIFFERENTIAL; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; UVEOMENINGOENCEPHALITIC SYNDROME;

EID: 27144452536     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530500232126     Document Type: Review

References (42)

1. Pattison EM. Uveomeningoencephalitic syndrome (Vogt-Koyanagi-Harada). Arch Neurol 1965; 12:197-205.
2. Sugiura S. Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol 1978; 22:9-35.
3. Kotake S, Furudate N, Sasamoto Y, Yoshikawa K, Goda C, Matsuda H. Characteristics of endogenous uveitis in Hokkaido, Japan. Graefes Arch Clin Exp Ophthalmol 1997; 235:5-9.
4. Read RW. Vogt-Koyanagi-Harada disease. Ophthalmol Clin North Am 2002; 15:333-41.
5. Gomi CF, Makdissi FF, Yamamoto JH, Olivalves E. [An epidemiologic study on uveitis.] Rev Med (São Paulo) 1997; 76:101-8.
6. Fernandes LC, Oréfice F. [Clinical and epidemiological aspects of uveitis in reference services from Belo Horizonte, from 1970 to 1993.] Part II. Rev Bras Oftal 1996; 55:19-32.
7. Snyder DA, Tessler HH. Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1980; 90:69-75.
8. Cunningham ET Jr, Demetrius R, Frieden IJ, Emery HM, Irvine AR, Good WV. Vogt-Koyanagi-Harada syndrome in a 4-year old child. Am J Ophthalmol 1995; 120:675-7.
9. Nussenblatt RB. Clinical studies of Vogt-Koyanagi-Harada's disease at the National Eye Institute, NIH, USA. Jpn J Ophthalmol 1988; 32:330-3.
10. Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 1991; 109:682-7.
11. Ohno S, Minakawa R, Matsuda H. Clinical studies of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol 1988; 32:334-43.
12. Sasamoto Y, Ohno S, Matsuda H. Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease. Ophthalmologica 1990; 201:162-7.
13. Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, Pivetti-Pezzi P, Tessler HH, Usui M. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001; 131:647-52.
14. Kamondi A, Szegedi A, Papp A, Seres A, Szirmai I. Vogt-Koyanagi-Harada disease presenting initially as aseptic meningoencephalitis. Eur J Neurol 2000; 7:719-22.
15. Kawano Y, Tawara A, Nishioka Y, Suyama Y, Sakamoto H, Inomata H. Ultrasound biomicroscopic analysis of transient shallow anterior chamber in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1996; 121:720-3.
16. Nakamura H, Tsukamoto H, Shibahara R, Nagai M, Mishima HK. Ultrasound biomicroscopy in the management of Vogt-Koyanagi-Harada disease. Acta Ophthalmol Scand 2000; 78:718-9.
17. Kishi A, Nao-I N, Sawada A. Ultrasound biomicroscopic findings of acute angle-closure glaucoma in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1996; 122:735-7.
18. Friedman AH, Deutsch-Sokol RH. Sugiura's sign. Perilimbal vitiligo in the Vogt-Koyanagi-Harada syndrome. Ophthalmology 1981; 88:1159-65.
19. Goto H, Rao NA. Sympathetic ophthalmia and Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin 1990; 30:279-85.
20. Lubin JR, Ni C, Albert DM. Clinicopathological study of the Vogt-Koyanagi-Harada syndrome. Int Ophthalmol Clin 1982; 22:141-56.
21. Hayasaka Y, Hayasaka S. Almost simultaneous onset of Vogt-Koyanagi-Harada syndrome in co-workers, friends, and neighbors. Graefes Arch Clin Exp Ophthalmol 2004; 242:611-3.
22. Bassili SS, Peyman GA, Gebhardt BM, Daun M, Ganiban GJ, Rifai A. Detection of Epstein-Barr virus DNA by polymerase chain reaction in the vitreous from a patient with Vogt-Koyanagi-Harada syndrome. Retina 1996; 16:160-1.
23. Schlaegel TF Jr, Morris WR. Viruslike inclusion bodies in sub-retinal fluid in uveo-encephalitis. Am J Ophthalmol 1964; 58: 940-5.
24. Shindo Y, Inoko H, Yamamoto T, Ohno S. HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410. Br J Ophthalmol 1994; 78:223-6.
25. Goldberg AC, Yamamoto JH, Chiarella JM, Marin ML, Sibinelli M, Neufeld R, Hirata CE, Olivalves E, Kalil J. HLA-DRB1*0405 is the predominant allele in Brazilian patients with Vogt-Koyanagi-Harada disease. Hum Immunol 1998; 59:183-8.
26. Damico FM, Cunha-Neto E, Goldberg AC, Iwai LK, Marin ML, Hammer J, Kalil J, Yamamoto JH. T cell recognition and cytokine profile induced by melanocyte epitopes in HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis patients. Invest Ophthalmol Vis Sci 2005; 46:2465-71.
27. Gocho K, Kondo I, Yamaki K. Identification of autoreactive T cells in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci 2001; 42:2004-9.
28. Yamaki K, Gocho K, Hayakawa K, Kondo I, Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J Immunol 2000; 165:7323-9.
29. Yamaki K, Kondo I, Nakamura H, Miyano M, Konno S, Sakuragi S. Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats. Exp Eye Res 2000; 71:361-9.
30. Yamada K, Senju S, Nakatsura T, Murata Y, Ishihara M, Nakamura S, Ohno S, Negi A, Nishimura Y. Identification of a novel autoantigen UACA in patients with panuveitis. Biochem Biophys Res Commun 2001; 280:1169-76.
31. Chan CC, Palestine AG, Nussenblatt RB, Roberge FG, Benezra D. Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behcet's disease, and sympathetic ophthalmia. Ophthalmology 1985; 92:1025-8.
32. Rutzen AR, Ortega-Larrocea G, Schwab IR, Rao NA. Simultaneous onset of Vogt-Koyanagi-Harada syndrome in monozygotic twins. Am J Ophthalmol 1995 Feb; 119(2):239-40.
33. Gass JD. Acute posterior multifocal placoid pigment epitheliopathy. Arch Ophthalmol 1968 Aug; 80(2):177-85.
34. Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol 1995; 39:265-92.
35. Oshima Y, Harino S, Hara Y, Tano Y. Indocyanine green angiographic findings in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 1996; 122:58-66.
36. Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology 2001; 108:54-64.
37. Forster DJ, Cano MR, Green RL, Rao NA. Echographic features of the Vogt-Koyanagi-Harada syndrome. Arch Ophthalmol 1990; 108:1421-6.
38. Read RW, VKH Therapy Group. Poster 2664: A retrospective multi-national survey of current treatment patterns in acute and subacute Vogt-Koyanagi-Harada disease. 2004 Association for Research in Vision and Ophthalmology Annual Meeting. Fort Lauderdale, FL, April 25-29.
39. Paredes IP, Ahmed M, Foster CS. Poster 2663: Immunomodulatory therapy for VKH patients as a first line therapy. 2004 Association for Research in Vision and Ophthalmology Annual Meeting. Fort Lauderdale, FL, April 25-29.
40. Wakatsuki Y, Kogure M, Takahashi Y, Oguro Y. Combination therapy with cyclosponn A and steroid in severe case of Vogt-Koyanagi-Harada's disease. Jpn J Ophthalmol 1988; 32:358-60.
41. Read RW, Rechodouni A, Butani N, Johnston R, LaBree LD, Smith RE, Rao NA. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001; 131:599-606.
42. Yamamoto JH, Damico FM, Hirata CE, Kubo PY, Goldberg AC, Kalil J, Olivalves E. Epidemiological and clinical features of Brazilian patients with Vogt-Koyanagi-Harada syndrome. In: Dodds EM, Couto CA, editors. Uveitis in the Third Millennium. Amsterdam, The Netherlands: Elsevier Science B.V., 2000; 175-8.